Get in Touch

P4A developed a bespoke Launch Guidebook to ensure the successful launch of a new asset

  • Digital Solutions
Wonderful tool: dynamic and intuitive. So much useful content to be leveraged by our teams 

Commercial Lead

Client Challenge

Preparing for the launch of an asset that was unfamiliar to the company and representing a new disease area.

A mid-sized company acquired their first rare disease treatment.

Our client needed support with navigating this unfamiliar situation

P4A Solution

A bespoke digital PDF Guidebook was carefully tailored to the asset, the indication and our client’s needs across functional teams & markets.

The Guidebook clearly outlined the essential steps, timelines and resources needed to achieve launch success.

The Successful Outcome​

  • The Guidebook has been widely welcomed across the company; users reported feeling reassured & supported throughout the development of their launch plans
  • The Guidebook was used and accessed within just two weeks of rollout over 1,000 times
  • Global uptake surpassed the company’s target by over

Need more details?

Do you want to learn more about the successful outcome for this case study? Are you interested in P4A Services or just want to say Hi?

get in touch

Explore other case studies

Understand evidence requirements beyond clinical trial data for launching an orphan drug in Türkiye & the GCC

  • Access Strategy

Optimising the PRMA potential of an orphan oncology asset in EU4 + UK and Japan

  • Access Strategy, Price Optimisation
p4a-logo-small-retina-white

We are award winning global experts in access for orphan drugs and Cell and Gene Therapies.

Twitter Instagram Youtube Linkedin

About

Services

Insights

Case Studies

Contact

  • Aramislaan 88,
  • 6213BV Maastricht, Netherlands
  • +31 6 55 88 71 96
  • contact@partners4access.com

P4A Services

For all access and Rare Disease related overview enquiries